Molecular Bias
- 1 September 2005
- journal article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 20 (9) , 739-745
- https://doi.org/10.1007/s10654-005-2028-1
Abstract
Bias is ubiquitous in research. The advent of the molecular era provides a unique opportunity to study the consequences of bias with large-scale empirical evidence accumulated in the massive data produced by the current discovery-oriented scientific effort, rather than just with theoretical speculations and constructs. Here I discuss some empirical evidence about manifestations of bias in molecular epidemiology. Bias may manifest as either heterogeneity or as deviation from the true estimates. The failure to translate molecular knowledge and the failure to replicate information are some typical hallmarks of bias at action. The acquired knowledge about the behaviour and manifestations of bias in molecular fields can be transferred back also to more traditional fields of epidemiology and medical research. Getting rid of false claims of the past is at least as important as producing new scientific discoveries. In many fields, the observed effects sizes that circulate as established knowledge are practically estimating only the net bias that has operated in the field all along. Issues of plausibility (in particular biological plausibility), replication, and credibility that form the theoretical basis of epidemiology and etiological inference can now be approached with large-scale empirical data.Keywords
This publication has 36 references indexed in Scilit:
- Commentary: Grading the credibility of molecular evidence for complex diseasesInternational Journal of Epidemiology, 2006
- Differentiating Biases from Genuine Heterogeneity: Distinguishing Artifactual from Substantive EffectsPublished by Wiley ,2005
- Why Most Published Research Findings Are FalsePLoS Medicine, 2005
- Contradicted and Initially Stronger Effects in Highly Cited Clinical ResearchJAMA, 2005
- Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical CompaniesPLoS Medicine, 2005
- Lessons from Controversy: Ovarian Cancer Screening and Serum ProteomicsJNCI Journal of the National Cancer Institute, 2005
- Bias in analytic researchPublished by Elsevier ,2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Recursive Cumulative Meta-analysis: A Diagnostic for the Evolution of Total Randomized Evidence from Group and Individual Patient DataJournal of Clinical Epidemiology, 1999
- Keynote addresses. Meta‐analysis: Reconciling the results of independent studiesStatistics in Medicine, 1995